dabrafenib and trametinib

Mon, 16 Oct 2023 16:11:17 -0400
For the treatment of pediatric patients 1 year of age and older with low-grade glioma with a BRAF V600E mutation who require systemic therapy.

For the treatment of pediatric patients 1 year of age and older with high-grade glioma with a BRAF V600E mutation who have received at least one prior radiation and/or chemotherapy treatment.